Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial
- Author
- PACKER, M1 ; COLUCCI, W. S2 ; GOTTLIEB, S. S9 ; PEARLE, D10 ; CODY, R. J11 ; GREGORY, J. J12 ; KANTROWITZ, N. E6 ; LEJEMTEL, T. H; YOUNG, S. T13 14 ; LUKAS, M. A14 ; SHUSTERMAN, N. H14 ; SACKNER-BERNSTEIN, J. D1 ; LIANG, C.-S3 ; GOLDSCHER, D. A4 ; FREEMAN, I5 ; KUKIN, M. L6 ; KINHAL, V7 ; UDELSON, J. E8 ; KLAPHOLZ, M1
[1] College of Physicians and Surgeons, Columbia University, New York, NY, United States
[2] Boston (Mass) University School of Medicine, United States
[3] University of Rochester (NY) School of Medicine, United States
[4] Good Samaritan Hospital, Baltimore, Md, United States
[5] Nassau County Medical Center, East Meadow, NY, United States
[6] Mount Sinai School of Medicine, New York, NY, United States
[7] Henry Ford Hospital, Grosse Pointe, Mich, United States
[8] Tufts University School of Medicine, Boston, Mass, United States
[9] University of Maryland, Baltimore, United States
[10] Georgetown University School of Medicine, Washington, DC, United States
[11] Ohio State University School of Medicine, Columbus, United States
[12] Overlook Hospital, Summit, NJ, United States
[13] Albert Einstein School of Medicine, Bronx, NY, United States
[14] SmithKline Beecham Pharmaceuticals, King of Prussia, Pa, United States
PRECISE Study Group - Source
Circulation (New York, N.Y.). 1996, Vol 94, Num 11, pp 2793-2799 ; ref : 50 ref
- CODEN
- CIRCAZ
- ISSN
- 0009-7322
- Scientific domain
- Cardiology, blood circulation, phlebology
- Publisher
- Lippincott Williams & Wilkins, Hagerstown, MD
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Antiarythmique Bloquant β-adrénergique Carvédilol Chimiothérapie Homme Indice gravité Insuffisance cardiaque Traitement Appareil circulatoire pathologie Cardiopathie
- Keyword (en)
- Antiarrhythmic agent Beta blocking agent Carvedilol Chemotherapy Human Severity score Heart failure Treatment Cardiovascular disease Heart disease
- Keyword (es)
- Antiarrítmico Bloqueador β-adrenérgico Carvedilol Quimioterapia Hombre Indicio gravedad Insuficiencia cardíaca Tratamiento Aparato circulatorio patología Cardiopatía
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02F Cardiovascular system / 002B02F02 Antiarythmic agents
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 2510091
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Access to the document
Install on your browser
DOI
10.1161/01.CIR.94.11.2793 
https://dx.doi.org/10.1161/01.CIR.94.11.2793
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1161\/01.CIR.94.11.2793\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"94\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2793\";s:8:\"\u0000*\u0000epage\";s:4:\"2799\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PACKER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:13:\"COLUCCI, W. S\";i:1;s:14:\"GOTTLIEB, S. S\";i:2;s:9:\"PEARLE, D\";i:3;s:10:\"CODY, R. J\";i:4;s:13:\"GREGORY, J. J\";i:5;s:16:\"KANTROWITZ, N. E\";i:6;s:14:\"LEJEMTEL, T. H\";i:7;s:11:\"YOUNG, S. T\";i:8;s:11:\"LUKAS, M. A\";i:9;s:16:\"SHUSTERMAN, N. H\";i:10;s:23:\"SACKNER-BERNSTEIN, J. D\";i:11;s:11:\"LIANG, C.-S\";i:12;s:15:\"GOLDSCHER, D. A\";i:13;s:10:\"FREEMAN, I\";i:14;s:11:\"KUKIN, M. L\";i:15;s:9:\"KINHAL, V\";i:16;s:13:\"UDELSON, J. E\";i:17;s:11:\"KLAPHOLZ, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1161\/01.CIR.94.11.2793\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"94\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2793\";s:8:\"\u0000*\u0000epage\";s:4:\"2799\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PACKER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:13:\"COLUCCI, W. S\";i:1;s:14:\"GOTTLIEB, S. S\";i:2;s:9:\"PEARLE, D\";i:3;s:10:\"CODY, R. J\";i:4;s:13:\"GREGORY, J. J\";i:5;s:16:\"KANTROWITZ, N. E\";i:6;s:14:\"LEJEMTEL, T. H\";i:7;s:11:\"YOUNG, S. T\";i:8;s:11:\"LUKAS, M. A\";i:9;s:16:\"SHUSTERMAN, N. H\";i:10;s:23:\"SACKNER-BERNSTEIN, J. D\";i:11;s:11:\"LIANG, C.-S\";i:12;s:15:\"GOLDSCHER, D. A\";i:13;s:10:\"FREEMAN, I\";i:14;s:11:\"KUKIN, M. L\";i:15;s:9:\"KINHAL, V\";i:16;s:13:\"UDELSON, J. E\";i:17;s:11:\"KLAPHOLZ, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:25:\"10.1161\/01.CIR.94.11.2793\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Unpaywall access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1161\/01.CIR.94.11.2793\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"94\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2793\";s:8:\"\u0000*\u0000epage\";s:4:\"2799\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PACKER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:13:\"COLUCCI, W. S\";i:1;s:14:\"GOTTLIEB, S. S\";i:2;s:9:\"PEARLE, D\";i:3;s:10:\"CODY, R. J\";i:4;s:13:\"GREGORY, J. J\";i:5;s:16:\"KANTROWITZ, N. E\";i:6;s:14:\"LEJEMTEL, T. H\";i:7;s:11:\"YOUNG, S. T\";i:8;s:11:\"LUKAS, M. A\";i:9;s:16:\"SHUSTERMAN, N. H\";i:10;s:23:\"SACKNER-BERNSTEIN, J. D\";i:11;s:11:\"LIANG, C.-S\";i:12;s:15:\"GOLDSCHER, D. A\";i:13;s:10:\"FREEMAN, I\";i:14;s:11:\"KUKIN, M. L\";i:15;s:9:\"KINHAL, V\";i:16;s:13:\"UDELSON, J. E\";i:17;s:11:\"KLAPHOLZ, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1161\/01.CIR.94.11.2793\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"94\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2793\";s:8:\"\u0000*\u0000epage\";s:4:\"2799\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PACKER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:13:\"COLUCCI, W. S\";i:1;s:14:\"GOTTLIEB, S. S\";i:2;s:9:\"PEARLE, D\";i:3;s:10:\"CODY, R. J\";i:4;s:13:\"GREGORY, J. J\";i:5;s:16:\"KANTROWITZ, N. E\";i:6;s:14:\"LEJEMTEL, T. H\";i:7;s:11:\"YOUNG, S. T\";i:8;s:11:\"LUKAS, M. A\";i:9;s:16:\"SHUSTERMAN, N. H\";i:10;s:23:\"SACKNER-BERNSTEIN, J. D\";i:11;s:11:\"LIANG, C.-S\";i:12;s:15:\"GOLDSCHER, D. A\";i:13;s:10:\"FREEMAN, I\";i:14;s:11:\"KUKIN, M. L\";i:15;s:9:\"KINHAL, V\";i:16;s:13:\"UDELSON, J. E\";i:17;s:11:\"KLAPHOLZ, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:25:\"10.1161\/01.CIR.94.11.2793\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:9:\"\u0000*\u0000jtitle\";s:28:\"Circulation (New York, N.Y.)\";s:9:\"\u0000*\u0000stitle\";s:24:\"Circulation (N. Y. N.Y.)\";s:7:\"\u0000*\u0000date\";s:4:\"1996\";s:9:\"\u0000*\u0000volume\";s:2:\"94\";s:8:\"\u0000*\u0000issue\";s:2:\"11\";s:8:\"\u0000*\u0000spage\";s:4:\"2793\";s:8:\"\u0000*\u0000epage\";s:4:\"2799\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0009-7322\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:6:\"PACKER\";s:10:\"\u0000*\u0000aufirst\";s:1:\"M\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:18:{i:0;s:13:\"COLUCCI, W. S\";i:1;s:14:\"GOTTLIEB, S. S\";i:2;s:9:\"PEARLE, D\";i:3;s:10:\"CODY, R. J\";i:4;s:13:\"GREGORY, J. J\";i:5;s:16:\"KANTROWITZ, N. E\";i:6;s:14:\"LEJEMTEL, T. H\";i:7;s:11:\"YOUNG, S. T\";i:8;s:11:\"LUKAS, M. A\";i:9;s:16:\"SHUSTERMAN, N. H\";i:10;s:23:\"SACKNER-BERNSTEIN, J. D\";i:11;s:11:\"LIANG, C.-S\";i:12;s:15:\"GOLDSCHER, D. A\";i:13;s:10:\"FREEMAN, I\";i:14;s:11:\"KUKIN, M. L\";i:15;s:9:\"KINHAL, V\";i:16;s:13:\"UDELSON, J. E\";i:17;s:11:\"KLAPHOLZ, M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CIRCAZ\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:137:\"Double-blind, placebo-controlled study of the effects of carvedilol in patients with moderate to severe heart failure : The PRECISE trial\";s:8:\"\u0000*\u0000place\";s:14:\"Hagerstown, MD\";s:6:\"\u0000*\u0000pub\";s:29:\"Lippincott Williams & Wilkins\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
